Ryan & Maniskas, LLP (
) is investigating potential claims against the board of directors of Emergent Group Inc. ("Emergent" or the "Company") (AMEX:LZR) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell Emergent to Universal Hospital Services, Inc. (“UHS”) in a transaction valued at approximately $70 million.
Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of Emergent. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
Under the proposed agreement, UHS will make a cash tender offer of $8.46 per share for all outstanding shares of Emergent after a “go-shop” period of 21 days.
If you own shares of Emergent and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit:
. You may also email Mr. Maniskas at
. For more information about class action cases in general, please visit our website:
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.